Immunological Modulation by 1α,25-Dihydroxyvitamin D3 in Patients With Squamous Cell Carcinoma of the Head and Neck

Cytokine - United States
doi 10.1016/j.cyto.2012.03.002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Advances on Synthesis of 1α,25-Dihydroxyvitamin D3 and Related Analogues

Journal of Organic Chemistry Research
2014English

SOX2 Activation Predicts Prognosis in Patients With Head and Neck Squamous Cell Carcinoma

Scientific Reports
Multidisciplinary
2018English

Head and Neck: Oral Squamous Cell Carcinoma

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Cutaneous Squamous Cell Carcinoma of the Head and Neck

Journal of Skin Cancer
DermatologyOncology
2011English

Evaluation of Xerostomia in Patients With Head and Neck Squamous Cell Carcinoma Treated With Radiotherapy

Journal of Cancer Therapy
2020English

1α,25-Dihydroxyvitamin D3 Rapidly Modulates Ca2+ Influx in Osteoblasts Mediated by Ca2+ Channels

The Bulletin of Tokyo Dental College
Medicine
2010English

Expression of P53 and Prognosis in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)

International Journal of Cancer and Clinical Research
2019English

Differences in History of Sexual Behavior Between Patients With Oropharyngeal Squamous Cell Carcinoma and Patients With Squamous Cell Carcinoma at Other Head and Neck Sites

Head and Neck
Otorhinolaryngology
2010English

Cyclin D1 Polymorphism and Expression in Patients With Squamous Cell Carcinoma of the Head and Neck

American Journal of Pathology
Forensic MedicinePathology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy